Zajícová A, Holán V
Institute of Molecular Genetics, Czechoslovak Academy of Sciences, Praha.
Folia Biol (Praha). 1990;36(6):301-11.
Spleen cells from mice bearing progressively growing syngeneic methylcholanthrene-induced sarcomas are immunologically hyporeactive and also their proliferative responses to interleukin-1 (IL-1) or interleukin-2 (IL-2) stimulation are considerably decreased. The hypo-reactivity to IL-2, but not to IL-1, is due to an active suppression: spleen cells from tumour-bearing mice inhibit the IL-2-induced proliferation of cells from normal donors. Supernatants obtained after cultivation of spleen cells from mice bearing tumours show similar suppressive effects. The hyporeactivity to IL-2 and IL-1 in tumour-bearerers is not improved by indomethacin, an inhibitor of prostaglandin synthesis. The results show that the low reactivity to IL-2 in tumour-bearing mice is due to an active suppression mediated by spleen cells and their factor(s) and that more different mechanisms regulate responsiveness to interleukins in tumour-bearing hosts.
携带逐渐生长的同基因甲基胆蒽诱导肉瘤的小鼠的脾细胞免疫反应低下,并且它们对白细胞介素-1(IL-1)或白细胞介素-2(IL-2)刺激的增殖反应也显著降低。对IL-2而非IL-1的低反应性是由于一种活性抑制:荷瘤小鼠的脾细胞抑制正常供体细胞的IL-2诱导的增殖。荷瘤小鼠脾细胞培养后获得的上清液显示出类似的抑制作用。吲哚美辛(一种前列腺素合成抑制剂)并不能改善荷瘤者对IL-2和IL-1的低反应性。结果表明,荷瘤小鼠对IL-2的低反应性是由于脾细胞及其因子介导的活性抑制,并且在荷瘤宿主中,更多不同的机制调节对白细胞介素的反应性。